In 2024 semaglutide (Wegovy) became the first weight loss drug to also be approved for the reduction of risk of serious cardiovascular events in patients with cardiovascular disease and obesity or overweight
The gentle formula and jelly consistency make it suitable for sensitive and easily irritated skin types
Carotenoids as natural functional pigments
It is also important for converting food into energy and supporting cell growth and division
All authors called for further large-scale studies
When to See a Doctor Prompt medical evaluation is warranted if one or more of the following symptoms occur after the injection treatment: Increased pain or swelling at the injection site that progressively worsens Fever, chills, and/or night sweats Uncontrolled or excessive bleeding at the injection site Persistent numbness or weakness in the neck, shoulder, arm, or upper back Headaches Swelling in the arms Before considering a rotator cuff injection, patients are advised to discuss the risks, benefits, and alternative treatments with their doctor.
